Omeros Shares Tumble 6.7%, Retail Investors Bear Brunt of $60M Market Cap Loss
A sharp sell-off last week erased $60 million from Omeros Corporation's market value, with its predominantly retail shareholder base feeling the deepest impact. The decline highlights the risks and influence of individual investors in the biotech firm's ownership structure.